申请人:Walsh Kenneth B.
公开号:US20110281278A1
公开(公告)日:2011-11-17
In certain embodiments of the present disclosure, a method for determining an inhibitor of acetylcholine-activated potassium channel is described. The method includes incubating a cardiac cell in a solution comprising a test compound. The method further includes adding a muscarine (M2) receptor agonist to the cardiac cell in the solution and monitoring the cardiac cell for a change in membrane potential. A statistically insignificant change in the membrane potential following addition of the muscarine (M2) receptor to the solution signifies that the test compound is a K
+
channel blocker that inhibits opening of the acetylcholine-activated potassium channel.